Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-07-22

FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer HealthCare LLC)

View source ↗

Summary

FDA approved a supplemental NDA for Claritin RediTabs (loratadine) by Bayer HealthCare LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Claritin RediTabs (Loratadine)

Snippet

SUPPL AP for CLARITIN REDITABS (LORATADINE)